Moderna, Inc.
RNA Technology for Product Pipeline Research - Medical / Health Care - Medical Research
FromModerna, Inc.
Our product pipeline shows the progress we’re making on clinical programs currently in development to create mRNA medicines for a wide range of diseases and conditions. We are proud of the advancements we’ve made in pioneering new mRNA vaccines and treatments that may have the potential to treat and prevent rare diseases.
Most popular related searches
non-small cell lung cancer
vascular endothelial growth factor
medical research
lung cancer
colorectal cancer
vascular endothelial
cancer vaccine
respiratory syncytial
clinical program
healthcare research
Abbreviations:
- AZ: AstraZeneca
- CMV: cytomegalovirus
- CRC: colorectal cancer
- G6Pase: glucose 6-phosphatase
- hMPV: human metapneumovirus
- IL12: interleukin 12
- IL23: interleukin 23
- IL36γ: interleukin 36 gamma
- MUT: methylmalonyl-CoA mutase
- NSCLC: non-small cell lung cancer
- PAH: phenylalanine hydroxylase
- PCCA/PCCB: propionyl-CoA carboxylase subunit A/B
- PCV: personalized cancer vaccine
- PIV3: human parainfluenza 3
- RSV: respiratory syncytial virus
- VEGF-A: vascular endothelial growth factor A
Stay in the loop!
Select your areas of interest to receive industry updates.